Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation

NCT07516444 is registered in ClinicalTrials.gov with VDyne, Inc. as lead sponsor.

NCT NCT07516444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07516444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation
Lead sponsor
VDyne, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
July 28, 2026
Completion date
June 30, 2036
Enrollment
730 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases (cvd), heart valve diseases, randomized controlled trial (rct), severe heart valve disease, symptomatic tricuspid regurgitation, tricuspid valve disease, tricuspid valve insufficiency, tricuspid valve regurgitation